Zhejiang Huakang Pharmaceutical Co., Ltd. Stock

Equities

605077

CNE100005477

Food Processing

End-of-day quote Shanghai S.E. 06:00:00 2024-05-13 pm EDT 5-day change 1st Jan Change
23.17 CNY -1.70% Intraday chart for Zhejiang Huakang Pharmaceutical Co., Ltd. +5.85% +7.07%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site
Sales 2024 * 3.59B 496M Sales 2025 * 4.27B 590M Capitalization 5.29B 732M
Net income 2024 * - Net income 2025 * - EV / Sales 2024 * 1.47 x
Net cash position 2024 * - 0 Net cash position 2025 * - 0 EV / Sales 2025 * 1.24 x
P/E ratio 2024 *
-
P/E ratio 2025 *
-
Employees 1,350
Yield 2024 *
-
Yield 2025 *
-
Free-Float 43.98%
More Fundamentals * Assessed data
Dynamic Chart
Zhejiang Huakang Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Certain A Shares of Zhejiang Huakang Pharmaceutical Co., Ltd. are subject to a Lock-Up Agreement Ending on 10-FEB-2024. CI
Zhoushan Huakang Biotechnology Co., Ltd. announced that it expects to receive CNY 700 million in funding from Zhejiang Huakang Pharmaceutical Co., Ltd. CI
Huakang Pharmaceutical Earmarks 248 Million Yuan for Corn Oil, Maltodextrin Plants MT
Zhejiang Huakang Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Zhejiang Huakang Pharmaceutical Co., Ltd.(XSSC:605077) added to S&P Global BMI Index CI
Zhejiang Huakang Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
HY Energy Plans to Sell Remaining Stake in Huakang Pharma CI
Zhejiang Huakang Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Zhejiang Huakang Pharma Selling 1.3 Billion Yuan Convertible Bonds to Fund New Factory MT
Zhejiang Huakang Pharmaceutical Co., Ltd. (SHSE:605077completed the acquisition of 95% each on Zhejiang Huahe Thermal Power Co., Ltd. and Zhoushan Xinyisheng Trading Co., Ltd. from Ningbo Ruishunjiu Trading Co., Ltd. CI
Zhejiang Huakang Pharma to Buy 95% of Thermal Power Firm for 522.5 Million Yuan MT
Zhejiang Huakang Pharmaceutical Co., Ltd. agreed to sign the Equity Transfer Agreement to acquire 95% each on Zhejiang Huahe Thermal Power Co., Ltd. and Zhoushan Xinyisheng Trading Co., Ltd. from Ningbo Ruishunjiu Trading Co., Ltd. for CNY 522.5 million. CI
Zhejiang Huakang Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
HY Energy Plans to Unload Stake in Zhejiang Huakang Pharma CI
More news
1 day-1.70%
1 week+5.85%
Current month+9.45%
1 month+18.58%
3 months+23.18%
6 months+3.21%
Current year+7.07%
More quotes
1 week
22.50
Extreme 22.5
26.15
1 month
18.57
Extreme 18.57
26.15
Current year
15.57
Extreme 15.57
26.15
1 year
15.57
Extreme 15.57
28.07
3 years
15.57
Extreme 15.57
38.86
5 years
15.57
Extreme 15.57
64.08
10 years
15.57
Extreme 15.57
64.08
More quotes
Managers TitleAgeSince
Chief Executive Officer 55 01-06-30
Director of Finance/CFO 56 23-04-12
Chairman 56 04-03-31
Members of the board TitleAgeSince
Director of Finance/CFO 61 01-06-30
Director/Board Member 57 01-06-30
Director/Board Member 57 01-06-30
More insiders
Date Price Change Volume
24-05-13 23.17 -1.70% 3 036 094
24-05-13 23.57 -1.50% 3,785,446
24-05-10 23.93 -1.20% 7,394,531
24-05-09 24.22 +6.23% 6,827,851
24-05-08 22.8 +1.69% 4,870,242

End-of-day quote Shanghai S.E., May 13, 2024

More quotes
Zhejiang Huakang Pharmaceutical Co Ltd is a China-based company mainly engaged in the research and development, production and sales of a variety of functional sugar alcohols and starch sugar products. The Company's main products are xylitol, sorbitol, maltitol and grape syrup. Its products are mainly used in food, beverage, daily chemical and other fields. The Company conducts its businesses within the China market and to overseas markets such as Europe, America and Asia.
More about the company
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
23.17 CNY
Average target price
25 CNY
Spread / Average Target
+7.90%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 605077 Stock
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW